FDA approves USGI Medical’s pivotal study of the POSE2.0 procedure for primary obesity
The FDA has approved an USGI Medical’s Investigational Device Exemption application to conduct a pivotal study of its POSE2.0...
top of page
Browse by category
Search
USGI Medical completes Pilot Study of the POSE2.0 incisionless weight loss procedure
The FDA has acknowledged the successful completion of a pilot study of USGI Medical’s incisionless, endoscopic gastroplasty procedure,...
FDA approves expansion of POSE2.0 US pilot study evaluating incisionless weight loss procedure
The FDA has approved the expansion of a US- pilot study of the USGI Medical’s non-invasive, endoscopic procedure, known as POSE2.0. The...
Browse by tag
bottom of page